Details of the Drug

General Information of Drug (ID: DMG1CCR)

Drug Name

Anti-CEA designer T cell therapy

Synonyms

Anti-CEA designer T cells, Beth Israel; Engineered T cells, Harvard/Immunomedics; Anti-CEA designer T cell therapy, Harvard/Immunomedics; Gene therapy (CEA+ adenocarcinoma), Beth Israel; Gene therapy (carcinoembryonic antigen), Harvard/Immunomedics; Gene therapy (CEA+ adenocarcinoma), Harvard/Immunomedics; T cell gene therapy (CEA, colon tumor), Harvard/Immunomedics

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D0IS5Z

References

1	2nd Generation Anti-CEA Designer T Cells Resist Activation-Induced Cell Death, Proliferate on Tumor Contact, Secrete Cytokines and Exhibit Superior Anti-Tumor Activity In Vivo: A Preclinical Evaluation. Clin Cancer Res. 2008 December 15; 14(24): 8112-8122.